89th General Assembly · Iowa Funnel one-pager · Tuesday, November 10, 2026
SF 116: Relating to insurance coverage for prescription drugs used in the treatment of metastatic cancer and associated conditions, and including applicability provisions
Died when the session ended · The 2022 session adjourned on May 24, 2022, the General Assembly’s last regular session. Bills that didn’t pass both chambers died.
What it does
This bill relates to insurance coverage for prescription drugs used in the treatment of metastatic cancer. The bill requires policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs to provide coverage for prescription cancer drugs. “Prescription cancer drug” is defined in the bill as a prescription drug that is used to treat metastatic cancer or associated conditions. “Metastatic cancer” is also defined in the bill.
Sponsors
Not listed
Cost
No fiscal note
Senate subcommittee · named February 1, 2021
- Sen. Craig Johnson (R) · craig.johnson@legis.iowa.gov
- Sen. Waylon Brown (R)
- Sen. Janet Petersen (D) · janet.petersen@legis.iowa.gov
Lobbying · 3 for, 0 against
For: Iowa Hospital Association; Iowa Medical Society; Susan G. Komen Foundation
In plain words
- January 21, 2021Filed in the Senate and sent to the Commerce committee
- February 1, 2021Senate subcommittee named: Johnson, Brown and Petersen
From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Tuesday, November 10, 2026. https://iowafunnel.com/bills/89/SF116